Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
4.71
Dollar change
-0.05
Percentage change
-1.05
%
IndexRUT P/E- EPS (ttm)-0.35 Insider Own15.62% Shs Outstand544.91M Perf Week3.97%
Market Cap2.79B Forward P/E- EPS next Y-0.15 Insider Trans-2.13% Shs Float500.46M Perf Month-7.47%
Income-201.40M PEG- EPS next Q-0.10 Inst Own58.21% Short Float9.40% Perf Quarter24.93%
Sales0.52M P/S5372.39 EPS this Y-10.16% Inst Trans-1.65% Short Ratio4.00 Perf Half Y123.22%
Book/sh0.58 P/B8.07 EPS next Y56.60% ROA-44.41% Short Interest47.05M Perf Year50.00%
Cash/sh0.75 P/C6.29 EPS next 5Y5.00% ROE-60.04% 52W Range1.64 - 5.34 Perf YTD123.22%
Dividend Est.- P/FCF- EPS past 5Y-16.08% ROI-56.11% 52W High-11.80% Beta0.48
Dividend TTM- Quick Ratio3.67 Sales past 5Y46.26% Gross Margin- 52W Low187.20% ATR (14)0.25
Dividend Ex-Date- Current Ratio3.67 EPS Y/Y TTM-0.29% Oper. Margin-40381.92% RSI (14)60.03 Volatility4.67% 5.15%
Employees141 Debt/Eq0.25 Sales Y/Y TTM5.26% Profit Margin-38730.00% Recom1.38 Target Price6.94
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-31.14% Payout- Rel Volume0.78 Prev Close4.76
Sales Surprise955.56% EPS Surprise5.96% Sales Q/Q1347.62% EarningsMay 02 BMO Avg Volume11.77M Price4.71
SMA203.27% SMA5013.54% SMA20070.88% Trades Volume9,213,961 Change-1.05%
Date Action Analyst Rating Change Price Target Change
Apr-30-24Downgrade Robert W. Baird Outperform → Neutral $4.50
Apr-29-24Initiated TD Cowen Buy $10
Mar-15-24Reiterated Needham Buy $4 → $5
Sep-12-23Upgrade Goldman Neutral → Buy $4
Mar-28-23Initiated Goldman Neutral $3
Oct-28-22Initiated Wedbush Outperform $5
Jul-28-22Resumed B. Riley Securities Buy $4
Nov-02-21Initiated Robert W. Baird Outperform $4
Feb-18-21Resumed B. Riley Securities Buy $4
Aug-03-20Initiated Stifel Buy $3
Jul-11-24 02:23PM
Jul-08-24 07:09PM
Jun-20-24 04:30PM
Jun-11-24 10:00AM
Jun-10-24 11:58AM
03:51PM Loading…
Jun-07-24 03:51PM
03:24PM
01:10PM
11:21AM
11:02AM
07:22AM
Jun-06-24 09:58PM
May-16-24 04:30PM
May-03-24 10:34AM
May-02-24 12:55PM
08:20AM Loading…
08:20AM
07:00AM
06:46AM
Apr-25-24 04:30PM
Apr-18-24 04:30PM
Apr-03-24 04:30PM
Mar-19-24 09:07AM
Mar-15-24 03:50PM
01:29PM
10:47AM
08:57AM
05:00AM
Mar-14-24 03:54PM
Mar-13-24 10:48AM
Mar-12-24 12:28PM
04:20PM Loading…
Mar-08-24 04:20PM
Feb-28-24 07:05AM
Feb-22-24 04:30PM
Feb-14-24 04:30PM
Jan-18-24 04:30PM
Jan-12-24 08:30AM
Dec-21-23 04:30PM
Dec-11-23 04:15PM
Dec-06-23 08:00AM
Dec-04-23 05:00AM
Nov-28-23 08:00AM
Nov-16-23 04:30PM
Nov-07-23 04:30PM
Nov-02-23 09:00AM
08:00AM
Oct-26-23 04:30PM
Oct-19-23 04:30PM
Oct-12-23 03:26PM
Sep-29-23 08:00AM
Sep-11-23 04:30PM
Sep-07-23 08:00AM
Sep-05-23 04:30PM
Aug-22-23 08:00AM
Aug-21-23 08:00AM
Aug-17-23 04:30PM
Aug-03-23 04:05PM
Jul-27-23 04:30PM
Jul-20-23 04:30PM
Jun-29-23 08:30AM
Jun-22-23 04:30PM
Jun-20-23 09:00AM
Jun-13-23 09:00AM
Jun-12-23 08:00AM
Jun-07-23 04:30PM
Jun-06-23 04:30PM
Jun-02-23 03:30PM
May-25-23 05:02PM
May-18-23 04:30PM
May-11-23 10:02AM
08:00AM
May-04-23 04:30PM
Apr-26-23 10:05AM
Apr-20-23 04:30PM
Apr-12-23 04:40PM
Mar-16-23 05:45PM
04:05PM
Mar-09-23 04:30PM
Feb-16-23 04:30PM
Feb-03-23 01:19PM
Jan-19-23 04:30PM
Jan-12-23 07:30AM
Jan-11-23 07:30AM
Jan-10-23 04:30PM
Jan-05-23 11:15PM
Jan-04-23 04:19PM
06:55AM
Jan-03-23 04:30PM
Dec-22-22 04:30PM
Dec-13-22 11:10AM
Dec-12-22 08:00AM
Dec-08-22 11:30AM
Dec-07-22 11:30AM
Dec-04-22 05:19PM
Nov-17-22 04:30PM
Nov-07-22 04:30PM
Nov-04-22 12:00AM
Nov-03-22 09:25AM
09:01AM
08:00AM
Oct-27-22 04:30PM
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GRETHLEIN ANDREW JEVP, Chief Operating OfficerJul 08 '24Option Exercise1.72674,3481,159,879674,348Jul 10 04:05 PM
GRETHLEIN ANDREW JEVP, Chief Operating OfficerJul 08 '24Sale4.56674,3483,073,0040Jul 10 04:05 PM
Kapur AnilEVP, Corp Strategy & CCOJun 10 '24Option Exercise1.06421,875447,188421,875Jun 12 04:05 PM
Feller FayeEVP, Chief Medical OfficerJun 10 '24Option Exercise1.19287,900341,693155,400Jun 12 04:05 PM
Kapur AnilEVP, Corp Strategy & CCOJun 10 '24Sale4.64421,8751,959,6090Jun 12 04:05 PM
Feller FayeEVP, Chief Medical OfficerJun 10 '24Sale4.63287,9001,334,1290Jun 12 04:05 PM
SCARLETT JOHN AChairman, President and CEOJun 04 '24Option Exercise2.54600,0001,524,000600,000Jun 05 04:05 PM
SCARLETT JOHN AChairman, President and CEOJun 04 '24Sale4.00600,0002,400,000600,000Jun 05 04:05 PM
LAWLIS V BRYANDirectorMay 15 '24Option Exercise1.9435,00067,90035,000May 17 04:05 PM
LAWLIS V BRYANDirectorMay 15 '24Sale3.7535,000131,2500May 17 04:05 PM
O'Farrell Elizabeth G.DirectorAug 24 '23Buy2.286,60715,0647,407Aug 24 08:52 PM
O'Farrell Elizabeth G.DirectorAug 24 '23Buy2.286,57915,00026,220Aug 24 08:52 PM